Latest data on gross domestic spending on R&D, which is defined as the total expenditure (current and capital) on R&D carried out by all resident companies, research institutes, university and government laboratories, etc., in a country.
OECD countries are developing strategies to improve the quality of life of those affected by dementia. Sharing and linking population-based health and health care data with detailed clinical and biological data to create an international resource could be one of these strategies.
This booklet describes the work that OECD is doing to address the human health and environmental safety implications associated with the use of manufactured nanomaterials.
Synthetic biology is a powerful and transformative technique which merges biology and engineering. It opens up enormous scientific, commercial, and health opportunities.
Work in the area of genetics and genomics undertaken by the OECD including guidelines, events and reports.